Shareholders in Medical Developments International (ASX:MVP) have lost 90%, as stock drops 13% this past week
With the stock having lost 13% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.
View our latest analysis for Medical Developments International
Given that Medical Developments International didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
In the last half decade, Medical Developments International saw its revenue increase by 11% per year. That's a fairly respectable growth rate. So the stock price fall of 14% per year seems pretty steep. The market can be a harsh master when your company is losing money and revenue growth disappoints.
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Medical Developments International stock, you should check out this free report showing analyst profit forecasts.
While the broader market gained around 12% in the last year, Medical Developments International shareholders lost 10%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, longer term shareholders are suffering worse, given the loss of 14% doled out over the last five years. We would want clear information suggesting the company will grow, before taking the view that the share price will stabilize. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Medical Developments International has 3 warning signs (and 2 which make us uncomfortable) we think you should know about.
Medical Developments International is not the only stock insiders are buying. So take a peek at this free list of small cap companies at attractive valuations which insiders have been buying.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 hours ago
- Yahoo
Evolution Mining Full Year 2025 Earnings: Beats Expectations
Explore Evolution Mining's Fair Values from the Community and select yours Evolution Mining (ASX:EVN) Full Year 2025 Results Key Financial Results Revenue: AU$4.35b (up 35% from FY 2024). Net income: AU$926.2m (up 119% from FY 2024). Profit margin: 21% (up from 13% in FY 2024). The increase in margin was driven by higher revenue. EPS: AU$0.47 (up from AU$0.22 in FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. EVN Production and Reserves Gold Production: 750.51 troy koz (716.7 troy koz in FY 2024) Number of mines: 6 (6 in FY 2024) Copper Production: 76,261 t (67,862 t in FY 2024) Number of mines: 2 (2 in FY 2024) Silver Production: 827.01 troy koz (773.77 troy koz in FY 2024) All figures shown in the chart above are for the trailing 12 month (TTM) period Evolution Mining Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) also surpassed analyst estimates by 4.8%. The primary driver behind last 12 months revenue was the Cowal segment contributing a total revenue of AU$1.45b (33% of total revenue). Notably, cost of sales worth AU$2.79b amounted to 64% of total revenue thereby underscoring the impact on earnings. The most substantial expense, totaling AU$506.0m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how EVN's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Metals and Mining industry in Australia. Performance of the Australian Metals and Mining industry. The company's shares are up 4.6% from a week ago. Risk Analysis You should learn about the 1 warning sign we've spotted with Evolution Mining. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 hours ago
- Yahoo
Qube Holdings Limited (ASX:QUB) Shares Could Be 43% Below Their Intrinsic Value Estimate
Explore Qube Holdings's Fair Values from the Community and select yours Key Insights The projected fair value for Qube Holdings is AU$7.82 based on 2 Stage Free Cash Flow to Equity Qube Holdings' AU$4.43 share price signals that it might be 43% undervalued The AU$4.32 analyst price target for QUB is 45% less than our estimate of fair value How far off is Qube Holdings Limited (ASX:QUB) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the forecast future cash flows of the company and discounting them back to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. It may sound complicated, but actually it is quite simple! We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Crunching The Numbers We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value: 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 Levered FCF (A$, Millions) AU$229.5m AU$368.2m AU$481.6m AU$590.0m AU$688.5m AU$775.4m AU$851.1m AU$917.2m AU$975.6m AU$1.03b Growth Rate Estimate Source Analyst x3 Analyst x2 Est @ 30.82% Est @ 22.51% Est @ 16.69% Est @ 12.62% Est @ 9.76% Est @ 7.77% Est @ 6.37% Est @ 5.39% Present Value (A$, Millions) Discounted @ 8.2% AU$212 AU$315 AU$381 AU$431 AU$465 AU$485 AU$492 AU$490 AU$482 AU$470 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = AU$4.2b We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (3.1%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 8.2%. Terminal Value (TV)= FCF2035 × (1 + g) ÷ (r – g) = AU$1.0b× (1 + 3.1%) ÷ (8.2%– 3.1%) = AU$21b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= AU$21b÷ ( 1 + 8.2%)10= AU$9.6b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is AU$14b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of AU$4.4, the company appears quite good value at a 43% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. The Assumptions The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Qube Holdings as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.2%, which is based on a levered beta of 1.198. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. View our latest analysis for Qube Holdings SWOT Analysis for Qube Holdings Strength Earnings growth over the past year exceeded the industry. Debt is well covered by cash flow. Weakness Earnings growth over the past year is below its 5-year average. Interest payments on debt are not well covered. Dividend is low compared to the top 25% of dividend payers in the Infrastructure market. Opportunity Annual earnings are forecast to grow faster than the Australian market. Trading below our estimate of fair value by more than 20%. Threat Paying a dividend but company has no free cash flows. Revenue is forecast to grow slower than 20% per year. Moving On: Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Why is the intrinsic value higher than the current share price? For Qube Holdings, there are three essential items you should assess: Risks: Be aware that Qube Holdings is showing 1 warning sign in our investment analysis , you should know about... Future Earnings: How does QUB's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the ASX every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
16 hours ago
- Yahoo
AGL Energy Full Year 2025 Earnings: Revenues Beat Expectations, EPS Lags
AGL Energy (ASX:AGL) Full Year 2025 Results Key Financial Results Revenue: AU$14.4b (up 6.0% from FY 2024). Net loss: AU$98.0m (down by 114% from AU$711.0m profit in FY 2024). AU$0.15 loss per share (down from AU$1.06 profit in FY 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period AGL Energy Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) missed analyst estimates. The primary driver behind last 12 months revenue was the Customer Markets segment contributing a total revenue of AU$9.43b (66% of total revenue). Notably, cost of sales worth AU$10.6b amounted to 74% of total revenue thereby underscoring the impact on how AGL's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 1.0% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Global Integrated Utilities industry. Performance of the market in Australia. The company's shares are down 14% from a week ago. Risk Analysis Before we wrap up, we've discovered 2 warning signs for AGL Energy (1 is a bit unpleasant!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
